Effect of the BCL2 Gene Polymorphism on Survival in Advanced-Stage Non-Small Cell Lung Cancer Patients Who Received Chemotherapy

Publisher： Karger

E-ISSN： 1423-0232|84|4|214-218

ISSN： 0030-2414

Source： Oncology, Vol.84, Iss.4, 2013-01, pp. : 214-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation‐Related Genetic Variations and Survival in Patients With Advanced Non–Small Cell Lung Cancer Receiving First‐Line Chemotherapy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 3, 2014-09 ,pp. : 360-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Significance of Pretreatment C-Reactive Protein in Patients with Advanced Nonsquamous, Non-Small Cell Lung Cancer Who Received Gefitinib

By  

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 355-362

Karger

Access to resources Recommend Favorite

Chemotherapy in Elderly Patients with Advanced Lung Cancer Part II: Treatment of Non-Small Cell Lung Cancer (NSCLC)

By  

Oncology Research and Treatment, Vol. 27, Iss. 6, 2004-12 ,pp. : 583-588

Karger

Access to resources Recommend Favorite

Prognostic Factors in Elderly Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 355-362

Karger

Access to resources Recommend Favorite

Patients of all ages with advanced non‐small cell lung cancer are not receiving chemotherapy

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 5, 2015-09 ,pp. : 337-338

John Wiley & Sons Inc

Access to resources Recommend Favorite